Eisai, Biogen get FDA approval for Alzheimer's drug
The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug lecanemab developed by Eisai Co Ltd and Biogen Inc for patients in the...
Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug lecanemab developed by Eisai Co Ltd and Biogen Inc for patients in the...
Middle-East Arab News and Opinion - Asharq Al-Awsat is the world’s premier pan-Arab daily newspaper, printed simultaneously each day on four continents in 14 cities
The USFood and Drug Administration on Friday approved the Alzheimer s drug lecanemab developed by Eisai Co Ltd and Biogen Inc for patients in the earl...
The FDA has just approved new medication for Alzheimer's patients. Leqembi (lecanemab-irmb), a medication for the treatment of Alzheimer's disease, has just received approval from the US Food and Drug Administration through the Accelerated Approval pathway.
The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of